Evidence map›Paper›PMID 39375864›Full record

ArticleACS synthetic biology2024

CRISPR-GEM: A Novel Machine Learning Model for CRISPR Genetic Target Discovery and Evaluation.

Joshua P Graham, Yu Zhang, Lifang He, Tomas Gonzalez-Fernandez

Abstract read
In one paragraph

Article in ACS synthetic biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The evolution of AI-integrated genome editing and its challenges.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Joshua P GrahamDepartment of Bioengineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
Yu ZhangDepartment of Bioengineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
Lifang HeDepartment of Computer Science and Engineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
Tomas Gonzalez-FernandezDepartment of Bioengineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States.ORCID 0000-0002-4646-0905

Funding

Surrogate Augmented Deep Predictive Learning for Retinopathy of PrematurityR21EY034179 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, HE, LIFANG · 2023 to 2023
$482k
NEI NIH HHS R21 EY034179
6 · The paper itself

Abstract

CRISPR gene editing strategies are shaping cell therapies through precise and tunable control over gene expression. However, limitations in safely delivering high quantities of CRISPR machinery demand careful target gene selection to achieve reliable therapeutic effects. Informed target gene selection requires a thorough understanding of the involvement of target genes in gene regulatory networks (GRNs) and thus their impact on cell phenotype. Effective decoding of these complex networks has been achieved using machine learning models, but current techniques are limited to single cell types and focus mainly on transcription factors, limiting their applicability to CRISPR strategies. To address this, we present CRISPR-GEM, a multilayer perceptron (MLP) based synthetic GRN constructed to accurately predict the downstream effects of CRISPR gene editing. First, input and output nodes are identified as differentially expressed genes between defined experimental and target cell/tissue types, respectively. Then, MLP training learns regulatory relationships in a black-box approach allowing accurate prediction of output gene expression using only input gene expression. Finally, CRISPR-mimetic perturbations are made to each input gene individually, and the resulting model predictions are compared to those for the target group to score and assess each input gene as a CRISPR candidate. The top scoring genes provided by CRISPR-GEM therefore best modulate experimental group GRNs to motivate transcriptomic shifts toward a target group phenotype. This machine learning model is the first of its kind for predicting optimal CRISPR target genes and serves as a powerful tool for enhanced CRISPR strategies across a range of cell therapies.

Indexed as

CRISPR-Cas SystemsGene EditingGene Regulatory NetworksMachine LearningClustered Regularly Interspaced Short Palindromic RepeatsHumansCRISPR gene editinggene regulatory networkmachine learningMSC chondrogenesisosteoarthritisregulatory T cell

Identifiers

PMID39375864
PMCPMC11494708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.